Viewing nowGlupa Tablets 850 mg (Metformin Hydrochloride)
Metformin Hydrochloride 850mg
Tablet · Prescription medication
(Darim Biotech Co., Ltd.)

MFDS item code 200101309 · Notified 2001.08.29 · Insurance code 664600060
Treatment of type 2 diabetes mellitus
This medication is used for patients with type 2 diabetes. It is administered when dietary management and exercise alone are insufficient to control blood sugar, or when sulfonylureas are ineffective or cause side effects. It helps to control blood sugar levels, contributing to stable management of blood sugar levels and improvement of diabetes symptoms.
The dose should be determined individually based on drug response and tolerability and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and determine the minimum dose required for adequate glycemic control, this medicine must be initiated at a low dose. Administer 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When the dose is up to 2000mg, it is usually divided into 2 doses daily, in the morning and evening. For doses above 2000mg, divide the dose into 3 administrations daily with meals; the maximum daily dose is 2550mg. During initiation and dose adjustment, measure fasting blood glucose to assess the response to treatment and determine the minimum effective dose. Measure blood glycated hemoglobin levels at approximately 3-month intervals. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In patients whose blood glucose was previously controlled with diet alone but is temporarily no longer controlled, a short course of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other symptoms that may increase the risk of lactic acidosis, with the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, divided into 2 doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, this medicine must be discontinued immediately.
Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, taken during or after a meal. Measure blood glucose levels after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.
This medication can cause severe lactic acidosis or hypoglycemia and should not be administered, especially to patients with impaired renal function or those suffering from acute diseases. Do not use in patients with moderate or severe renal impairment, dehydration, serious infections, acute myocardial infarction, or sepsis, as these conditions can affect renal function. It is also safe not to administer this medication to patients with acute or unstable heart failure. Treatment with this medication should be suspended before and after examinations using iodinated contrast agents, and can only be resumed after renal function has returned to normal. Administration is contraindicated in patients with hypersensitivity to this drug or other biguanides, in patients with type 1 diabetes, and in those with diabetic ketoacidosis. In patients with severe infections, severe traumatic systemic disorders, preoperative or postoperative patients, malnutrition, liver dysfunction, pulmonary embolism, and severe respiratory dysfunction, treatment with this medication should be temporarily suspended or used with caution. This medication can cause rare but serious side effects called lactic acidosis, so patients and caregivers should immediately inform healthcare professionals if they experience nonspecific symptoms such as fatigue, muscle pain, difficulty breathing, or abdominal pain. Gastrointestinal symptoms such as diarrhea, nausea, vomiting may commonly occur, and while these symptoms are usually temporary, treatment can be temporarily suspended in case of severe symptoms. Since this medication is excreted through the kidneys, renal function should be regularly monitored, and extra caution should be taken, particularly in older adults or those with renal impairment. Excessive alcohol intake may affect this medication and lactate metabolism, increasing the risk of lactic acidosis, so it should be avoided during treatment. In the case of unstable blood sugar control, especially in stressful situations such as infections or surgeries, treatment may be temporarily suspended, and insulin therapy may be initiated. This medication crosses the placenta; therefore, when used during pregnancy, the fetal growth status must be closely monitored, and it should not be used in pregnant women at risk of placental insufficiency or preeclampsia. In nursing mothers, this medication is secreted into breast milk, so they should consult with a physician to decide whether to discontinue breastfeeding or the medication. Use in children and adolescents should be carefully considered, especially in those under 10 years of age, as special precautions are necessary. In cases of overdose, lactic acidosis can occur which requires immediate medical intervention, and the drug can be removed via hemodialysis. Because this medication has numerous interactions with other drugs, patients taking other medications should inform their healthcare providers and should regularly monitor blood sugar and renal function. This medication does not cause weight gain and helps in blood sugar control and prevention of diabetes complications with long-term use. Keep out of reach of children, and ensure that it is not transferred to another container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius to safely preserve the medication's effectiveness.
White rectangular film-coated tablet
For domestic use: 500 tablets/bottle, 100 tablets, 30 tablets/bottle; for export: 500 tablets/bottle, 60 tablets/bottle, 60 tablets (10 tablets/PTPX6)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 850mg
Tablet · Prescription medication
(Darim Biotech Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.